We focus on supplying world-leading treatments for patients in the Russian Federation who suffer from the rare disease, hemophilia. We follow strict guidelines as defined in Good Distribution Practice to ensure that our products are delivered safely, on time, and in compliance with the requirements of medicines which must be carefully handled and within defined temperature limits.

About us

SG Biotech Sàrl is a pharmaceutical company registered in Zug Switzerland and WDA-licensed (Wholesale Distribution Authorization) by Swissmedic.

For Healthcare Professionals

Corporate Policy – JSC SG Biotech

Yaniv Levy,
Managing Director

Yulia Zaytseva, Managing Director

Paola Bandiera, Responsible Person

Liesbeth van Gool, Executive Assistant.

Jim McKiernan, Head of Operations

World Leading expertise

The company was established in 2016 and is a joint venture between Takeda Pharmaceuticals, a global company specializing in rare diseases, and Generium, a leading Russian Life Sciences company.

We are proud to work with Shire, a global leader in serving patients with rare diseases with treatments for hemophilia. In partnership with Takeda, we work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them.

News